• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低聚果糖饮食与益生菌联合干预对中国西部肠易激综合征症状的影响:一项随机对照试验。

Effect of the combined intervention of low-FODMAPs diet and probiotics on IBS symptoms in Western China: A randomized controlled trial.

作者信息

Liu Yingying, Jin Di, He Tian, Liao Xinyi, Shao Limei, Shi Lei, Liu Ling

机构信息

Department of Gastroenterology and Hepatology West China Hospital, Sichuan University Chengdu China.

Department of Urology West China Hospital of Sichuan University Chengdu China.

出版信息

Food Sci Nutr. 2024 Feb 29;12(6):3993-4004. doi: 10.1002/fsn3.4057. eCollection 2024 Jun.

DOI:10.1002/fsn3.4057
PMID:38873474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11167163/
Abstract

The effect of low-FODMAPs diet on irritable bowel syndrome (IBS) in Western China has not been reported. We aimed to investigate the effect of low-FODMAPs diet on IBS patients in the area and whether low-FODMAPs diet-induced alterations of microbiota could be improved through probiotics. IBS patients were randomized to the control group, low-FODMAPs diet group, probiotics group, or combined group. IBS Symptom Severity Score questionnaire (IBS-SSS) and IBS Quality of Life Score questionnaire (IBS-QOL) were completed at baseline, 2 and 4 weeks to evaluate the severity of symptoms. Fresh feces were collected for analyses of gut microbiota and short-chain fatty acids at baseline and 4 weeks after intervention. Seventy-three patients were included in the per protocol analysis. After intervention, there was significant improvement in IBS-SSS in the low-FODMAPs group (37.5%, 44.2%), probiotics group (51.4%, 62.0%), and combined group (34.1%, 40.4%) at both 2 weeks and 4 weeks, compared with the baseline ( < .05). In the low-FODMAPs group, the abundance of several microbiota (, , etc.) was significantly decreased. Furthermore, after the supplementation of probiotics in the combined group, the abundance of Genus_, , , , , , and was significantly increased, which was associated with the improvements of symptoms score in the correlation analysis. Our study confirmed the effectiveness and safety of short-term low-FODMAPs diet in IBS symptoms based on the Chinese diet in Western China. The combination of low-FODMAPs and probiotics plays a beneficial role in gut microbiota in IBS.

摘要

低聚果糖饮食对中国西部肠易激综合征(IBS)的影响尚未见报道。我们旨在研究低聚果糖饮食对该地区IBS患者的影响,以及低聚果糖饮食引起的微生物群改变是否可通过益生菌得到改善。IBS患者被随机分为对照组、低聚果糖饮食组、益生菌组或联合组。在基线、第2周和第4周完成IBS症状严重程度评分问卷(IBS-SSS)和IBS生活质量评分问卷(IBS-QOL),以评估症状的严重程度。在基线和干预后4周收集新鲜粪便,用于分析肠道微生物群和短链脂肪酸。73例患者纳入符合方案分析。干预后,低聚果糖饮食组在第2周和第4周的IBS-SSS均有显著改善(分别为37.5%、44.2%),益生菌组(分别为51.4%、62.0%)和联合组(分别为34.1%、40.4%),与基线相比差异有统计学意义(P<0.05)。在低聚果糖饮食组中,几种微生物群(如……等)的丰度显著降低。此外,联合组补充益生菌后,……属、……、……、……、……、……和……的丰度显著增加,在相关性分析中这与症状评分的改善相关。我们的研究证实了基于中国西部饮食的短期低聚果糖饮食对IBS症状的有效性和安全性。低聚果糖与益生菌联合对IBS患者的肠道微生物群发挥有益作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4118/11167163/caee510837dc/FSN3-12-3993-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4118/11167163/170d212cca09/FSN3-12-3993-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4118/11167163/c4d8d0babed3/FSN3-12-3993-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4118/11167163/caee510837dc/FSN3-12-3993-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4118/11167163/170d212cca09/FSN3-12-3993-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4118/11167163/c4d8d0babed3/FSN3-12-3993-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4118/11167163/caee510837dc/FSN3-12-3993-g002.jpg

相似文献

1
Effect of the combined intervention of low-FODMAPs diet and probiotics on IBS symptoms in Western China: A randomized controlled trial.低聚果糖饮食与益生菌联合干预对中国西部肠易激综合征症状的影响:一项随机对照试验。
Food Sci Nutr. 2024 Feb 29;12(6):3993-4004. doi: 10.1002/fsn3.4057. eCollection 2024 Jun.
2
Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial.基于网络的低 FODMAP 饮食与益生菌治疗肠易激综合征的长期疗效,包括对微生物组的 shotgun 分析:随机、双交叉临床试验。
J Med Internet Res. 2021 Dec 14;23(12):e30291. doi: 10.2196/30291.
3
A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.低 FODMAP 饮食可减轻肠易激综合征患者的症状,益生菌可恢复双歧杆菌属:一项随机对照试验。
Gastroenterology. 2017 Oct;153(4):936-947. doi: 10.1053/j.gastro.2017.06.010. Epub 2017 Jun 15.
4
A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.低 FODMAP 饮食可减轻肠易激综合征症状。
Gastroenterology. 2014 Jan;146(1):67-75.e5. doi: 10.1053/j.gastro.2013.09.046. Epub 2013 Sep 25.
5
Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs.通过重新引入特定的可发酵寡糖、双糖、单糖和多元醇来实现肠易激综合征的长期症状控制。
World J Gastroenterol. 2017 Jul 7;23(25):4632-4643. doi: 10.3748/wjg.v23.i25.4632.
6
Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial.低 FODMAP 饮食可改善肠易激综合征症状,优于传统饮食建议:一项随机对照试验。
Gastroenterology. 2015 Nov;149(6):1399-1407.e2. doi: 10.1053/j.gastro.2015.07.054. Epub 2015 Aug 5.
7
Fermentable oligo-, di-, monosaccharides, and polyols (FODMAPs), but not gluten, elicit modest symptoms of irritable bowel syndrome: a double-blind, placebo-controlled, randomized three-way crossover trial.可发酵的寡糖、二糖、单糖和多元醇(FODMAPs),而非麸质,可引发轻微的肠易激综合征症状:一项双盲、安慰剂对照、随机三交叉试验。
Am J Clin Nutr. 2022 Feb 9;115(2):344-352. doi: 10.1093/ajcn/nqab337.
8
Effects of FODMAPs and Gluten on Gut Microbiota and Their Association with the Metabolome in Irritable Bowel Syndrome: A Double-Blind, Randomized, Cross-Over Intervention Study.FODMAPs 和 gluten 对肠菌及其代谢组与肠易激综合征的关联:一项双盲、随机、交叉干预研究。
Nutrients. 2023 Jul 5;15(13):3045. doi: 10.3390/nu15133045.
9
Low FODMAP diet reduces gastrointestinal symptoms in irritable bowel syndrome and clinical response could be predicted by symptom severity: A randomized crossover trial.低 FODMAP 饮食可减轻肠易激综合征的胃肠道症状,且临床应答可根据症状严重程度预测:一项随机交叉试验。
Clin Nutr. 2022 Dec;41(12):2792-2800. doi: 10.1016/j.clnu.2022.11.001. Epub 2022 Nov 4.
10
Clinical effectiveness of adding probiotics to a low FODMAP diet: Randomized double-blind placebo-controlled study.在低FODMAP饮食中添加益生菌的临床效果:随机双盲安慰剂对照研究。
World J Clin Cases. 2021 Sep 6;9(25):7417-7432. doi: 10.12998/wjcc.v9.i25.7417.

引用本文的文献

1
Efficacy of a Low-FODMAP Diet on the Severity of Gastrointestinal Symptoms and Quality of Life in the Treatment of Gastrointestinal Disorders-A Systematic Review of Randomized Controlled Trials.低发酵性寡糖、双糖、单糖和多元醇饮食对胃肠道疾病治疗中胃肠道症状严重程度及生活质量的疗效——随机对照试验的系统评价
Nutrients. 2025 Jun 19;17(12):2045. doi: 10.3390/nu17122045.
2
Efficacy of Dietary Interventions for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.饮食干预对肠易激综合征的疗效:一项系统评价和网状Meta分析
J Clin Med. 2024 Dec 11;13(24):7531. doi: 10.3390/jcm13247531.
3
Metataxonomics and Metabolomics Profiles in Metabolic Dysfunction-Associated Fatty Liver Disease Patients on a "Navelina" Orange-Enriched Diet.

本文引用的文献

1
Faecal and urine metabolites, but not gut microbiota, may predict response to low FODMAP diet in irritable bowel syndrome.粪便和尿液代谢物,但不是肠道微生物群,可能可以预测对肠易激综合征低 FODMAP 饮食的反应。
Aliment Pharmacol Ther. 2023 Aug;58(4):404-416. doi: 10.1111/apt.17609. Epub 2023 Jun 14.
2
The Usefulness of the Low-FODMAP Diet with Limited Tryptophan Intake in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome.低 FODMAP 饮食联合有限色氨酸摄入在腹泻型肠易激综合征治疗中的作用。
Nutrients. 2023 Apr 11;15(8):1837. doi: 10.3390/nu15081837.
3
Update on treatment of abdominal pain in irritable bowel syndrome: A narrative review.
代谢组学和代谢组学特征在代谢功能相关的脂肪性肝病患者“Navelina”甜橙饮食干预下的变化。
Nutrients. 2024 Oct 18;16(20):3543. doi: 10.3390/nu16203543.
肠易激综合征腹痛治疗的最新进展:一篇叙述性综述。
Pharmacol Ther. 2023 May;245:108400. doi: 10.1016/j.pharmthera.2023.108400. Epub 2023 Mar 30.
4
, a Potent Probiotic, Alleviates Colitis via Acetate-Mediated IgA Response and Microbiota Restoration.一种强效益生菌通过乙酸介导的IgA反应和微生物群恢复来缓解结肠炎。
J Agric Food Chem. 2023 Feb 14. doi: 10.1021/acs.jafc.2c06697.
5
Butyrate producers, "The Sentinel of Gut": Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics.丁酸盐产生菌,“肠道哨兵”:它们在肠道中的意义及其与丁酸盐的关联及其他方面,以及作为微生物疗法的潜在用途。
Front Microbiol. 2023 Jan 12;13:1103836. doi: 10.3389/fmicb.2022.1103836. eCollection 2022.
6
Diet and irritable bowel syndrome: an update from a UK consensus meeting.饮食与肠易激综合征:来自英国共识会议的最新更新。
BMC Med. 2022 Sep 13;20(1):287. doi: 10.1186/s12916-022-02496-w.
7
Effects of a low FODMAP diet on the colonic microbiome in irritable bowel syndrome: a systematic review with meta-analysis.低 FODMAP 饮食对肠易激综合征结肠微生物组的影响:系统评价与荟萃分析。
Am J Clin Nutr. 2022 Oct 6;116(4):943-952. doi: 10.1093/ajcn/nqac176.
8
Intestinal Microbiota-Derived Short Chain Fatty Acids in Host Health and Disease.肠道微生物衍生的短链脂肪酸在宿主健康和疾病中的作用。
Nutrients. 2022 May 9;14(9):1977. doi: 10.3390/nu14091977.
9
Microbiota in health and diseases.肠道菌群与健康和疾病。
Signal Transduct Target Ther. 2022 Apr 23;7(1):135. doi: 10.1038/s41392-022-00974-4.
10
AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review.美国胃肠病学会关于饮食在肠易激综合征中作用的临床实践更新:专家综述。
Gastroenterology. 2022 May;162(6):1737-1745.e5. doi: 10.1053/j.gastro.2021.12.248. Epub 2022 Mar 23.